Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 November 2007:
Vol. 318. no. 5852, pp. 977 - 980
DOI: 10.1126/science.1147379
Prev | Table of Contents | Next

Reports

Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38

Xiaochun Bai,1,3 Dongzhu Ma,1 Anling Liu,1 Xiaoyun Shen,1 Qiming J. Wang,1 Yongjian Liu,2 Yu Jiang1*

The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase (GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein (FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)–dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.

1 Department of Pharmacology, University of Pittsburgh School of Medicine, E1357 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
2 Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
3 Department of Cell Biology, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.

* To whom correspondence should be addressed. E-mail: jiang{at}server.pharm.pitt.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth.
H. A. Acosta-Jaquez, J. A. Keller, K. G. Foster, B. Ekim, G. A. Soliman, E. P. Feener, B. A. Ballif, and D. C. Fingar (2009)
Mol. Cell. Biol. 29, 4308-4324
   Abstract »    Full Text »    PDF »
Glycolytic Flux Signals to mTOR through Glyceraldehyde-3-Phosphate Dehydrogenase-Mediated Regulation of Rheb.
M. N. Lee, S. H. Ha, J. Kim, A. Koh, C. S. Lee, J. H. Kim, H. Jeon, D.-H. Kim, P.-G. Suh, and S. H. Ryu (2009)
Mol. Cell. Biol. 29, 3991-4001
   Abstract »    Full Text »    PDF »
Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic {beta}-Cells Leads to Increased {beta}-Cell Mass and Prevention of Hyperglycemia.
S. Hamada, K. Hara, T. Hamada, H. Yasuda, H. Moriyama, R. Nakayama, M. Nagata, and K. Yokono (2009)
Diabetes 58, 1321-1332
   Abstract »    Full Text »    PDF »
Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein.
T. Sato, A. Nakashima, L. Guo, and F. Tamanoi (2009)
J. Biol. Chem. 284, 12783-12791
   Abstract »    Full Text »    PDF »
Atg5 Regulates Phenethyl Isothiocyanate-Induced Autophagic and Apoptotic Cell Death in Human Prostate Cancer Cells.
A. Bommareddy, E.-R. Hahm, D. Xiao, A. A. Powolny, A. L. Fisher, Y. Jiang, and S. V. Singh (2009)
Cancer Res. 69, 3704-3712
   Abstract »    Full Text »    PDF »
Amino acid regulation of TOR complex 1.
J. Avruch, X. Long, S. Ortiz-Vega, J. Rapley, A. Papageorgiou, and N. Dai (2009)
Am J Physiol Endocrinol Metab 296, E592-E602
   Abstract »    Full Text »    PDF »
The TSC-mTOR Pathway Mediates Translational Activation of TOP mRNAs by Insulin Largely in a Raptor- or Rictor-Independent Manner.
I. Patursky-Polischuk, M. Stolovich-Rain, M. Hausner-Hanochi, J. Kasir, N. Cybulski, J. Avruch, M. A. Ruegg, M. N. Hall, and O. Meyuhas (2009)
Mol. Cell. Biol. 29, 640-649
   Abstract »    Full Text »    PDF »
The Rheb-mTOR Pathway Is Upregulated in Reactive Astrocytes of the Injured Spinal Cord.
S. Codeluppi, C. I. Svensson, M. P. Hefferan, F. Valencia, M. D. Silldorff, M. Oshiro, M. Marsala, and E. B. Pasquale (2009)
J. Neurosci. 29, 1093-1104
   Abstract »    Full Text »    PDF »
Making synaptic plasticity and memory last: mechanisms of translational regulation.
J. D. Richter and E. Klann (2009)
Genes & Dev. 23, 1-11
   Abstract »    Full Text »    PDF »
RalA Functions as an Indispensable Signal Mediator for the Nutrient-sensing System.
T. Maehama, M. Tanaka, H. Nishina, M. Murakami, Y. Kanaho, and K. Hanada (2008)
J. Biol. Chem. 283, 35053-35059
   Abstract »    Full Text »    PDF »
Characterization of TCTP, the Translationally Controlled Tumor Protein, from Arabidopsis thaliana.
O. Berkowitz, R. Jost, S. Pollmann, and J. Masle (2008)
PLANT CELL 20, 3430-3447
   Abstract »    Full Text »    PDF »
Isolation of Hyperactive Mutants of Mammalian Target of Rapamycin.
Y. Ohne, T. Takahara, R. Hatakeyama, T. Matsuzaki, M. Noda, N. Mizushima, and T. Maeda (2008)
J. Biol. Chem. 283, 31861-31870
   Abstract »    Full Text »    PDF »
Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling.
X. Wang, B. D. Fonseca, H. Tang, R. Liu, A. Elia, M. J. Clemens, U.-A. Bommer, and C. G. Proud (2008)
J. Biol. Chem. 283, 30482-30492
   Abstract »    Full Text »    PDF »
AMP-activated Protein Kinase Contributes to UV- and H2O2-induced Apoptosis in Human Skin Keratinocytes.
C. Cao, S. Lu, R. Kivlin, B. Wallin, E. Card, A. Bagdasarian, T. Tamakloe, W.-m. Chu, K.-l. Guan, and Y. Wan (2008)
J. Biol. Chem. 283, 28897-28908
   Abstract »    Full Text »    PDF »
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.
M. Rosner and M. Hengstschlager (2008)
Hum. Mol. Genet. 17, 2934-2948
   Abstract »    Full Text »    PDF »
The Switch I Region of Rheb Is Critical for Its Interaction with FKBP38.
D. Ma, X. Bai, S. Guo, and Y. Jiang (2008)
J. Biol. Chem. 283, 25963-25970
   Abstract »    Full Text »    PDF »
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.
C. Nardella, Z. Chen, L. Salmena, A. Carracedo, A. Alimonti, A. Egia, B. Carver, W. Gerald, C. Cordon-Cardo, and P. P. Pandolfi (2008)
Genes & Dev. 22, 2172-2177
   Abstract »    Full Text »    PDF »
HER3 Is a Determinant for Poor Prognosis in Melanoma.
M. Reschke, D. Mihic-Probst, E. H. van der Horst, P. Knyazev, P. J. Wild, M. Hutterer, S. Meyer, R. Dummer, H. Moch, and A. Ullrich (2008)
Clin. Cancer Res. 14, 5188-5197
   Abstract »    Full Text »    PDF »
Phospholipase D1 is an effector of Rheb in the mTOR pathway.
Y. Sun, Y. Fang, M.-S. Yoon, C. Zhang, M. Roccio, F. J. Zwartkruis, M. Armstrong, H. A. Brown, and J. Chen (2008)
PNAS 105, 8286-8291
   Abstract »    Full Text »    PDF »
Regulation of apoptosis and neurite extension by FKBP38 is required for neural tube formation in the mouse..
M. Shirane, M. Ogawa, J. Motoyama, and K. I. Nakayama (2008)
Genes Cells 13, 635-651
   Abstract »    Full Text »    PDF »
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies.
J. A. Garcia and D. Danielpour (2008)
Mol. Cancer Ther. 7, 1347-1354
   Abstract »    Full Text »    PDF »
Expression and Maintenance of Mitochondrial DNA: New Insights into Human Disease Pathology.
G. S. Shadel (2008)
Am. J. Pathol. 172, 1445-1456
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)